|
2025
|
Invention
|
Mageb2 binding constructs.
The present invention relates to antibody constructs comprising a dom... |
|
|
Invention
|
Antibody constructs for dll3 and cd3.
The present invention relates to a bispecific antibody con... |
|
|
Invention
|
Cd19-selective t cell engaging molecule for treating autoimmune diseases/ autoimmune conditions. ... |
|
|
Invention
|
Anti-ccr8 antibodies and uses thereof.
The present invention provides anti-CCR8 antibodies and a... |
|
|
Invention
|
Binding molecules for bcma and cd3.
The present invention relates to a binding molecule which is... |
|
|
Invention
|
Psma and cd3 bispecific t cell engaging antibody constructs.
The present invention provides bisp... |
|
|
Invention
|
Cross-species-specific psmaxcd3 bispecific single chain antibody.
The present invention relates ... |
|
|
Invention
|
Bispecific t cell engaging antibody constructs.
The present invention provides bispecific antibo... |
|
|
Invention
|
Antibody constructs for msln and cd3.
The present invention relates to a bispecific antibody con... |
|
|
Invention
|
Dosing regimen for bcmax-cd3 antibodies constructs.
The present invention relates to an antibody... |
|
2024
|
Invention
|
Bispecific single chain antibody construct with enhanced tissue distribution.
The present invent... |
|
|
Invention
|
Methods for treating prostate cancer with bispecific antibodies binding steap1xcd3. The present d... |
|
|
Invention
|
Combination therapy for treating prostate cancer. The present disclosure provides methods of trea... |
|
|
Invention
|
Compositions comprising cross-species-specific antibodies and uses thereof.
The present inventio... |
|
|
Invention
|
Bispecific antibody constructs for cdh3 and cd3.
The present invention relates to a bispecific a... |
|
2023
|
Invention
|
Antibody constructs for cldn18.2 and cd3.
The present invention relates to an antibody construct... |
|
|
Invention
|
Multichain multitargeting bispecific antigen-binding molecules of increased selectivity. The pres... |
|
|
Invention
|
Single chain binding molecules comprising n-terminal abp.
The present invention relates to a sin... |
|
|
Invention
|
Heteromultimer binding dll3 and cd3.
The disclosure provides a heteromultimer comprising a first... |
|
|
Invention
|
Heteromultimer binding dll3 and cd3. The disclosure provides a heteromultimer comprising a first ... |
|
|
Invention
|
Treatment of acute lymphoblastic leukemia.
The present invention relates to a method for the tre... |
|
2022
|
Invention
|
Antibody constructs for dll3 and cd3. The present invention relates to a bispecific antibody cons... |
|
|
Invention
|
Cross-species-specific binding domain.
The present invention relates to a polypeptide comprising... |
|
|
Invention
|
Subcutaneous administration of cd19-binding t cell engagers.
The present invention provides bisp... |
|
|
Invention
|
Subcutaneous administration of cd19-binding t cell engaging antibodies. The present invention in ... |
|
|
Invention
|
Antibody constructs for cdh19 and cd3. Provided are antibody constructs comprising a first human ... |
|
|
Invention
|
Treatment of pediatric acute lymphoblastic leukemia.
The present invention relates to a method f... |
|
|
Invention
|
Antibody constructs for flt3 and cd3.
The present invention relates to a bispecific antibody con... |
|
|
Invention
|
Pharmaceutical composition comprising bispecific antibody constructs.
The present invention prov... |
|
|
Invention
|
T cell engager molecules and uses thereof.
The present invention provides single chain T cell en... |
|
|
Invention
|
Anti-ccr8 antibodies and uses thereof. The present invention provides anti-CCR8 antibodies and an... |
|
|
Invention
|
T cell engager molecules and uses thereof. The present invention provides single chain T cell eng... |
|
|
Invention
|
Cd20 and cd22 targeting antigen-binding molecules for use in proliferative diseases.
The present... |
|
|
Invention
|
Methods for reducing low molecular weight species of recombinantly-produced proteins.
The presen... |
|
|
Invention
|
Systems for out-patient treatment of a patient, and related methods.
A system for out-patient tr... |
|
|
P/S
|
Medicaments, namely, polypeptides, for use in the treatment of tumorous diseases, cancer, allergi... |
|
|
Invention
|
Long life polypeptide binding molecules.
The present invention relates to a binding molecule com... |
|
2021
|
Invention
|
Diffusion gradient assay for anti-cd3-containing molecules.
The present disclosure provides mate... |
|
|
Invention
|
Mechanistic ion-exchange chromatography model calibratio18038891.
A method is provided, comprisi... |
|
|
Invention
|
Molecules with multiple binding domains.
New formats of multispecific molecules are described, a... |
|
|
Invention
|
Multitargeting bispecific antigen-binding molecules of increased selectivity.
The present invent... |
|
|
Invention
|
Polypeptide constructs binding to cd3.
The invention relates to a polypeptide or polypeptide con... |
|
|
Invention
|
Methods for administering therapeutic doses of bispecific t-cell engaging molecules for the treat... |
|
|
P/S
|
Medicaments, namely polypeptides, for use in the treatment of tumorous diseases, cancer, allergie... |
|
|
Invention
|
Bispecific antibody constructs for cdh3 and cd3. The present invention relates to a bispecific an... |
|
|
Invention
|
Cross-species-specific psmaxcd3 bispecific single chain antibody. The present invention relates t... |
|
|
Invention
|
Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof.... |
|
2020
|
Invention
|
Multitargeting antigen-binding molecules for use in proliferative diseases.
The present inventio... |
|
|
Invention
|
Dosage regimen for anti-egfrviii agents.
The invention provides a method for the treatment of EG... |
|
2005
|
P/S
|
Medicines, namely polypeptides, in particular antibodies and antibody derivatives. Scientific and... |
|
2000
|
P/S
|
[ Medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in... |
|
|
P/S
|
Medicaments, namely pharmaceutical and veterinary preparations, namely polypeptides, namely antib... |
|
|
P/S
|
Medicaments; pharmaceutical and veterinary preparations,
particularly polypeptides, antibodies a... |
